Crain’s New York Business, the trusted voice of the New York City-area business community, has recognized EmpiRx Health as a finalist for their 2023 Diversity & Inclusion Awards, in the “Diversity Champion – Medium-Sized Organization” category.

In their profile of EmpiRx Health (subscription required), Crain’s New York editors wrote:

The Montvale, New Jersey-based company has established relationships with local colleges that serve diverse student populations to broaden its pipeline of applicants. Last year, EmpiRx Health joined a consortium of health industry leaders supporting Dominican University of New York’s Public Health Informatics and Technology Program, one of several education-focused programs that keeps diversity at the forefront. The firm also has longstanding relationships with the pharmacy school programs at Touro College and Rutgers University.

About 70% of its employees are women and 40% are people of color.

Last year EmpiRx Health also joined the Techquity for Health Coalition, an effort led by the nonprofit HLTH Foundation to better factor health equity considerations into health care technology and data practices.

The company’s chief people officer, Alisia Gill, thinks companies can move beyond “performative DEI,” according to a column she wrote earlier this year in Human Resource Executive about how to drive real organizational change.

“Small and mid-sized companies are often among the most intentional and effective champions of DE&I – and yet, our efforts are often overshadowed by the immense resources of larger organizations,” says Gill. “It is essential to shed light on the incredible strides made by smaller enterprises in fostering a culture of diversity and inclusion. Thank you to Crain’s New York, not only for recognizing EmpiRx Health commitment to Diversity and Inclusion, but for recognizing all the small- and medium-sized Diversity Champions finalists.”

Crain’s will reveal the winners of the D&I awards during an in-person event at the New York Athletic Club in Manhattan on June 13, 2023.